home / stock / crdf / crdf articles


CRDF Articles, Cardiff Oncology Inc. - From 03/01/24

Stock Information

Company Name: Cardiff Oncology Inc.
Stock Symbol: CRDF
Market: NASDAQ
Website: cardiffoncology.com

Menu

CRDF CRDF Quote CRDF Short CRDF News CRDF Articles CRDF Message Board
Get CRDF Alerts

News, Short Squeeze, Breakout and More Instantly...

Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected thir...

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC | Benzinga

- New clinical data from second-line randomized ONSEMBLE trial provides further evidence of the efficacy of onvansertib in combination with FOLFIR...

Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference | Benzinga

SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibi...

Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying | Benzinga

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern ...

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 152.8% to $1.09. The company announced the effective date for its reverse stock split after ...

Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 69.9% to $0.7391 in pre-market trading. The company announced the effective date for its revers...

Why Cardiff Oncology Stock Is Rising After Hours | Benzinga

Cardiff Oncology, Inc. (NASDAQ: CRDF) shares are trading higher Tuesday after-hours after the company announced clinical data in pancreatic cancer ...

Previous 10 Next 10